Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Disrupting SORL1-retromer endosomal recycling in mice drives the age-dependent neurodegenerative signature of Alzheimer's disease 2026-10-30
  2. TMEM106B C-Terminal fragment aggregation exacerbates α-synuclein and TDP-43 proteinopathy phenotypes 2026-10-30
  3. The Filamin A Proteomic Switch: Solubility States and Cytoskeletal Dynamics Explain the Inverse Epidemiological Relationship Between Cancer and Alzheimer’s Disease 2026-10-26

Studies

240 studies carry this tag.

Date range

1993 to 2026

Top journals

  • Autophagy 9
  • bioRxiv 9
  • Nature 8
  • Nature communications 6
  • Acta neuropathologica 5

145 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Disrupting SORL1-retromer endosomal recycling in mice drives the age-dependent neurodegenerative signature of Alzheimer's disease

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-10-30 Genetics

    MRI studies have mapped the atrophic signature that distinguishes Alzheimer's disease (AD), isolating regions differentially vulnerable to its age-dependent neurodegenerative process.

  2. TMEM106B C-Terminal fragment aggregation exacerbates α-synuclein and TDP-43 proteinopathy phenotypes

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-10-30 Brain tissue and pathology

    Genetic variation in the human gene encoding the lysosomal transmembrane protein 106B (TMEM106B) drives risk of neurodegenerative dementia.

  3. The Filamin A Proteomic Switch: Solubility States and Cytoskeletal Dynamics Explain the Inverse Epidemiological Relationship Between Cancer and Alzheimer’s Disease

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2026-10-26 Genetics

    This structural configuration shields the scaffold from calpain-mediated cleavage, reconfiguring FLNA into an active motility engine driving invasive lamellipodia but stalls proteolytic processing and forces an absolute loss of the nuclear FLNA-90 tumor-suppressor brake, unleashing uninhibited c-Myc oncogenic transcription.

  4. TMEM55B downregulation promotes neurodegeneration in Alzheimer’s disease models

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-10-24 Brain scans and imaging

    Lysosomal distribution is critical for numerous biological functions within the cell, including protein degradation in autophagosomes, cholesterol homeostasis, and cell invasion.

  5. The Alzheimer’s disease risk gene ABCA7 regulates microglial lysosomal and lipid homeostasis and promotes phagocytosis to maintain neuronal health

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-10-19 Disease mechanisms

    ABCA7-KO iMGs were deficient for proteins involved in lysosome function, measured by down-regulated lysosomal proteomic signatures, as well as reduced DQ-BSA activity and reduced LAMP1+ area.

  6. Intrastriatal injection of amplified Lewy body dementia (LBD) fibrils in mice results in accumulation of fibrils with LBD structure and neurodegeneration

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-10-13 Brain tissue and pathology

    The defining neuropathologic feature of Lewy body dementia (LBD) and Parkinson’s disease (PD) is alpha-synuclein (Asyn) fibril accumulation in Lewy bodies (LBs) and Lewy neurites (LNs).

  7. ALS-associated mutations reveal a conserved C-terminal self-assembly module in the TDP-43 low-complexity domain

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-10-12 Brain tissue and pathology

    TAR DNA-binding protein 43 (TDP-43) is an RNA-binding protein whose low-complexity domain (LCD) mediates self-assembly, liquid-liquid phase separation, and pathological aggregation associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

  8. An astrocyte-neuron HSPB1 axis preserves lysosomal integrity and protects from tau pathology

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Research Square 2026-10-12 Disease mechanisms

    Alzheimer’s disease (AD) is characterized by a decline in neuronal proteostasis that favours the accumulation of misfolded proteins.

  9. Genetically distinct neurodegenerative proteinopathies engage overlapping proteostasis components

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-10-04 Disease mechanisms

    Neurodegenerative proteinopathies are defined by distinct proteins whose folding, trafficking and clearance depend on shared proteostasis machinery.

  10. Repetitive RNA Is Present in Prion-Infected Mouse Brains

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2026-10-02 Drug development

    Scrapie, a prion disease, is usually considered a protein-only infection.

  11. Early life social isolation primes flies for more rapid TDP-43 dependent neurodegeneration later in life

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-09-28 Risk factors

    A key pathophysiological hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is loss of nuclear localization and abnormal cytoplasmic aggregation of TAR DNA-binding protein 43 (TDP-43).

  12. Rab11-exosome biogenesis regulators mediate Aβ-induced intercellular propagation of endolysosomal trafficking defects and neurodegeneration

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. bioRxiv 2026-09-20 Risk genes beyond APOE

    Alzheimer’s Disease (AD) is characterised by two histopathological hallmarks, intracellular tau-containing neurofibrillary tangles and extracellular amyloid plaques containing β-amyloid (Aβ), a specific cleavage product of Amyloid Precursor Protein (APP).

  13. Atrophy signature for alpha-synuclein copathology in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Alzheimer's & dementia (Amsterdam, Netherlands) 2026-05-24 Brain tissue and pathology

    Compared to CTR, both AD-αSAA- and AD-αSAA+ showed widespread cortical thinning.

  14. A Biophysical Framework for Neurodegeneration: Prioritizing Protein Homeostasis Over Aggregate Toxicity

    ⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Preprints.org 2025-12-31 Treatments

    Neurodegenerative research has long hypothesized that aggregated proteins such as amyloid‑β (Aβ), tau, and α‑synuclein (αSyn) are intrinsically toxic and are directly associated with the etiologies of Alzheimer’s disease (AD) and Parkinson’s disease (PD).

  15. NAD+ restores proteostasis through splicing-dependent autophagy

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Autophagy 2025-12-29 Disease mechanisms

    Autophagy preserves neuronal integrity by clearing damaged proteins and organelles, but its efficiency declines with aging and neurodegeneration.

  16. Early proteasome downregulation and dysfunction drive proteostasis failure in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Brain : a journal of neurology 2025-12-04 Disease mechanisms

    Here, we integrated multiple approaches to characterize proteasome function, composition and regulation in post-mortem human AD brain tissue compared with age-matched controls.

  17. Unfolded proteins and aggregates: The role of proteostasis in pseudoexfoliation pathology

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular vision 2025-11-17 Disease mechanisms

    Evidence indicates that chronic proteotoxic stress, arising from aging, oxidative damage, and environmental influences, disrupts the proteostasis network (PN).

  18. Co-infection with two α-synuclein strains reveals novel synergistic interactions

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Acta neuropathologica 2025-11-08 Brain tissue and pathology

    In synucleinopathies, the protein α-synuclein misfolds into Lewy bodies (LBs) in patients with Lewy body disease (LBD) or into glial cytoplasmic inclusions (GCIs) in patients with multiple system atrophy (MSA).

  19. Rethinking neurodegeneration through a co-proteinopathy lens

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Trends in neurosciences 2025-11-06 Brain tissue and pathology

    Neurodegenerative diseases have long been considered distinct proteinopathies: amyloid-β and tau in Alzheimer's disease, α-synuclein in Parkinson's disease, and TDP-43 in amyotrophic lateral sclerosis.

  20. TDP-43-proteinopathy at the crossroads of tauopathy: on copathology and current and prospective biomarkers

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in cellular neuroscience 2025-10-28 Brain tissue and pathology

    Though usually described as isolated models, neurodegenerative diseases exist in a significant proportion of cases as mixed pathologies, particularly in older adults.

  21. Protein misfolding and its dual role in neurodegeneration and cancer progression

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Advances in protein chemistry and structural biology 2025-10-26 Disease mechanisms

    Protein misfolding is a fundamental biological process with profound implications for human health and disease.

  22. LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Acta neuropathologica 2025-10-23 Brain tissue and pathology

    Parkinson's disease (PD) pathogenic mutations in leucine-rich repeat kinase 2 (LRRK2) are associated with endolysosomal dysfunction across cell types, and carriers of LRRK2 mutations variably present with phosphorylated tau and α-synuclein deposits in post-mortem analysis.

  23. Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Acta neuropathologica 2025-10-14 Disease mechanisms

    The autophagy-lysosome pathway (ALP) and the ubiquitin-proteasome system (UPS) are the primary protein degradative mechanisms maintaining proteostasis in neurons.

  24. Hyperactive 20S proteasome enhances proteostasis and ERAD in C. elegans via degradation of intrinsically disordered proteins

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Science advances 2025-10-10 Disease mechanisms

    Age-related proteinopathies, including Alzheimer's and Parkinson's disease, are driven by toxic accumulation of misfolded and intrinsically disordered proteins (IDPs) that overwhelm cellular proteostasis.

  25. Optineurin deficiency disrupts phosphorylated tau proteostasis and clusterin expression in human neurons

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Acta neuropathologica communications 2025-09-02 Disease mechanisms

    Optineurin (OPTN) is an autophagy adaptor protein involved in selective autophagy, including aggrephagy and mitophagy.

  26. PINK1 deficiency permits the development of Lewy body dementia with coexisting Aβ pathology

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-09 Brain tissue and pathology

    DLB brains show PINK1 deficiency alongside α-syn and Aβ co-pathology.

  27. Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-08 Disease mechanisms

    Diabetic retinopathy (DR) and Alzheimer's disease (AD) are progressive neurodegenerative disorders affecting the eye and the brain, respectively.

  28. Autophagy and Alzheimer's Disease: Mechanisms and Impact Beyond the Brain

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Cells 2025-06-16 Disease mechanisms

    Alzheimer's disease (AD) is a progressive neurodegenerative disorder marked by neuronal loss, cognitive decline, and pathological hallmarks such as amyloid-beta (Aβ) plaques and tau neurofibrillary tangles.

  29. Physical exercise mitigates the cognitive impairments by promoting ER-phagy in mice model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Behavioural brain research 2025-05-23 Disease mechanisms

    Alzheimer's disease (AD) is the primary cause of dementia in older individuals, exhibiting an increasing incidence worldwide.

  30. In the present study, we found senescent aVICs exhibited impaired macroautophagy/autophagy as evidenced by compromised autophagy flux and immature autophagosomes.

  31. Sex-specific and cell-type-specific changes in chaperone-mediated autophagy across tissues during aging

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Nature aging 2025-02-05 Disease mechanisms

    Aging leads to progressive decline in organ and tissue integrity and function, partly due to loss of proteostasis and autophagy malfunctioning.

  32. Genetically Engineered Mouse Models for Alzheimer Disease and Frontotemporal Dementia: New Insights from Single-Cell and Spatial Transcriptomics

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. The American journal of pathology 2024-12-19 Genetics

    Neurodegenerative diseases, including Alzheimer disease, frontotemporal dementia, Parkinson disease, Huntington disease, and amyotrophic lateral sclerosis, are often casually linked to protein aggregation and inclusion.

  33. Chaperone-mediated autophagy as a modulator of aging and longevity

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in aging 2024-12-02 Disease mechanisms

    Chaperone-mediated autophagy (CMA) is the lysosomal degradation of individually selected proteins, independent of vesicle fusion.

  34. Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer's disease-relevant brain circuits

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Nature communications 2024-11-29 Disease mechanisms

    Rare mutations in the gene encoding presenilin2 (PSEN2) are known to cause familial Alzheimer's disease (FAD).

  35. [Disease-modifying Drugs for non-Alzheimer Dementias]

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Brain and nerve = Shinkei kenkyu no shinpo 2024-09 Brain tissue and pathology

    Neurodegenerative diseases represent the most common cause of dementia.

  36. HLH-30/TFEB modulates autophagy to improve proteostasis in Aβ transgenic Caenorhabditis elegans

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Frontiers in pharmacology 2024-08-30 Disease mechanisms

    Alzheimer's disease (AD) is a complex neurodegenerative disease that affects elderly individuals, characterized by senile plaques formed by extracellular amyloid beta (Aβ).

  37. Proteostasis disruption and senescence in Alzheimer's disease pathways to neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Brain research 2024-08-30 Disease mechanisms

    Alzheimer's Disease (AD) is a progressive neurological disease associated with behavioral abnormalities, memory loss, and cognitive impairment that cause major causes of dementia in the elderly.

  38. CCDC50 mediates the clearance of protein aggregates to prevent cellular proteotoxicity

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Autophagy 2024-07-30 Disease mechanisms

    Protein aggregation caused by the disruption of proteostasis will lead to cellular cytotoxicity and even cell death, which is implicated in multiple neurodegenerative diseases.

  39. Annexin A11 aggregation in FTLD-TDP type C and related neurodegenerative disease proteinopathies

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Acta neuropathologica 2024-06-19 Brain tissue and pathology

    TAR DNA-binding protein 43 (TDP-43) is an RNA binding protein found within ribonucleoprotein granules tethered to lysosomes via annexin A11.

  40. Tau fibrils evade autophagy by excessive p62 coating and TAX1BP1 exclusion

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Science advances 2024-06-12 Disease mechanisms

    The accumulation of protein aggregates is a hallmark of many diseases, including Alzheimer's disease.

  41. Proteostasis in neurodegenerative diseases

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Advances in clinical chemistry 2024-04-30 Disease mechanisms

    Proteostasis is essential for normal function of proteins and vital for cellular health and survival.

  42. α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Cell death & disease 2024-04-13 Disease mechanisms

    Cognitive dysfunction and dementia are critical symptoms of Lewy Body dementias (LBD).

  43. Role of autophagy and proteostasis in neurodegenerative diseases: Exploring the therapeutic interventions

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Chemical biology & drug design 2024-04 Disease mechanisms

    Neurodegenerative disorders are devastating disorders characterized by gradual loss of neurons and cognition or mobility impairment.

  44. ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Molecular therapy : the journal of the American Society of Gene Therapy 2024-02-29 Drug development

    Spinocerebellar ataxia type 3 (SCA3) is the most common dominantly inherited ataxia.

  45. Intersectin - many facets of a scaffold protein

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Biochemical Society transactions 2024-02-28 Prevention trials

    Intersectin (ITSN) is a multi-domain scaffold protein with a diverse array of functions including regulation of endocytosis, vesicle transport, and activation of various signal transduction pathways.

  46. Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer's disease profile and possible mechanisms of disease protection

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Neuron 2024-02-27 Genetics

    Highly penetrant autosomal dominant Alzheimer's disease (ADAD) comprises a distinct disease entity as compared to the far more prevalent form of AD in which common variants collectively contribute to risk.

  47. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Nature medicine 2024-01-26 Biomarkers

    Although loss of TAR DNA-binding protein 43 kDa (TDP-43) splicing repression is well documented in postmortem tissues of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), whether this abnormality occurs during early-stage disease remains unresolved.

  48. The autophagy of stress granules

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. FEBS letters 2023-12-21 Disease mechanisms

    Our understanding of stress granule (SG) biology has deepened considerably in recent years, and with this, increased understanding of links has been made between SGs and numerous neurodegenerative diseases.

  49. baz-2 enhances systemic proteostasis in vivo by regulating acetylcholine metabolism

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cell reports 2023-12-14 Disease mechanisms

    Neurodegenerative disorders, such as Alzheimer's disease (AD) or Huntington's disease (HD), are linked to protein aggregate neurotoxicity.

  50. Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. International journal of molecular sciences 2023-11-27 Drug development

    The spectrum of neurodegenerative diseases known today is quite extensive.

From across this tag

9 of the 240 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.

All topic tags with their study counts